THE RELATIVE BIOAVAILABILITY OF TWO MARKETED CONTROLLED RELEASE DILTIAZEM DOSAGE FORMS AT STEADY STATE IN HEALTHY VOLUNTEERS.

Autor: Lippert, C. L., Arumugham, T., Bhargava, V. O., Eller, M., Weir, S. J.

Publikováno v: Biopharmaceutics & Drug Disposition; 1996, Vol. 17 Issue 1, p43-53, 11p

Effect of ketoconazole on the pharmacokinetics and safety of telithromycin and clarithromycin in older subjects with renal impairment.

Autor: Shi J; Aventis, Global Biopharmaceutics and Clinical Pharmacokinetics, Drug Metabolism and Pharmacokinetics, 1041 Route 202 - 206, Bridgewater, NJ 08807-0800, USA. junshi88@yahoo.com, Chapel S, Montay G, Hardy P, Barrett JS, Sica D, Swan SK, Noveck R, Leroy B, Bhargava VO

Publikováno v: International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2005 Mar; Vol. 43 (3), pp. 123-33.

Relative bioavailability of Cardizem CD and Tiazac controlled-release diltiazem dosage forms after single and multiple dosing in healthy volunteers.

Autor: Dimmitt DC; North America Pharmacokinetics, Hoechst Marion Roussel, P.O. Box 9627, F4-M3112, Kansas City, MO 64134, USA., Bhargava VO, Arumugham T, Eller M, Weir SJ

Publikováno v: American journal of therapeutics [Am J Ther] 1998 May; Vol. 5 (3), pp. 173-9.

Pharmacokinetics of MDL 26479, a novel benzodiazepine inverse agonist, in normal volunteers.

Autor: Robbins DK; Department of Pharmacokinetics and Bioanalytics, Hoèchst Marion Roussel, Kansas City, MO 64134-0627, USA. USMARLDN@IBMMAIL.COM, Hutcheson SJ, Miller TD, Green VI, Bhargava VO, Weir SJ

Publikováno v: Biopharmaceutics & drug disposition [Biopharm Drug Dispos] 1997 May; Vol. 18 (4), pp. 325-34.

Percutaneous absorption of ketoprofen from different anatomical sites in man.

Autor: Shah AK; Pfizer Inc., Central Research Division, Groton, Connecticut 06340, USA., Wei G, Lanman RC, Bhargava VO, Weir SJ

Publikováno v: Pharmaceutical research [Pharm Res] 1996 Jan; Vol. 13 (1), pp. 168-72.